Company | Research & Development | International Bussiness | Partners | Performance | Addresses | Service

In our country, Cristália is a reference in the research of new substances, thanks to the work performed by its Pharmacochemical Development Center, one of the most modern and complete centers in Latin America.

Created in 1988, the Center has the high-level scientists, responsible for the development of 50 active ingredients or molecules, some of which new in the international market.

Cristália became the first Brazilian pharmaceutical industry to obtain the patent for the drug manufacturing process in the US. Get to know more about S-Ketamine, the product that contributed to one more of the company's accomplishments.

Some features have always been in Cristalia's history: Innovation is one of them. Today, Cristália is known for its investment in research & development and new molecules, three of which - still new and very promising -, are being submitted to tests required for the approval for therapeutic use.
Single Dose
Find out how Cristália overcame the drug identification problem in oral presentations.
Sterile Pack
Injection products packing system, specially developed for surgical center.
Site Map ©2004 Cristália - All rights reserved.